Online Program

Correlates of physicians' HPV vaccine recommendations for male patients: A national study

Tuesday, November 5, 2013

Teri Malo, PhD, MPH, Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
Anna Giuliano, PhD, Center for Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Jessica Kahn, MD, MPH, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH
Gregory Zimet, Ph.D., Pediatrics/ Adolescent Medicine, Indiana University School of Medicine, Indianapolis, IN
Ji-Hyun Lee, DrPH, Moffitt Cancer Center, Tampa, FL
Xiuhua Zhao, MPH, Moffitt Cancer Center, Tampa, FL
Susan Vadaparampil, PhD, MPH, Moffitt Cancer Center, Tampa, FL
Background: Physician recommendation influences human papillomavirus (HPV) vaccine uptake for females, yet little is known about physicians' recommendations for males. This study aimed to examine the prevalence and correlates of physicians' HPV vaccine recommendations to males ages 11-12, 13-17, and 18-26 years. Methods: National samples of family physicians and pediatricians were selected from the AMA Physician Masterfile (n=1,219). In April 2011, physicians were surveyed about HPV vaccine recommendations and their personal, practice, and patient characteristics. Physicians reported the frequency with which they recommended HPV vaccination to male patients in each age group (“always” [>75% of the time] vs. other). Correlates of vaccine recommendation were identified using multivariable logistic regression. Results: 406 family physicians (56.7% response rate) and 322 pediatricians (70.2%) returned completed surveys. The percentage of physicians “always” recommending vaccination was 10.8% for ages 11-12, 12.9% for ages 13-17, and 13.2% for ages 18-26. Pediatrician specialty and self-reported early adoption of new vaccines were associated with HPV vaccine recommendation to all age groups. Physician race and patient payment method were associated with recommendation to ages 11-12, whereas patient race was associated with recommendation to ages 13-17 and 18-26. Conclusions: Physicians' consistent HPV vaccine recommendation to males was low just prior to the Advisory Committee on Immunization Practices' change in guidelines from permissive to routine vaccination. Interventions to increase vaccine recommendations to all patient age groups may need to target family physicians. Additionally, identifying and supporting early adopters may help diffuse HPV vaccination guidelines and encourage later adopters to follow guidelines.

Learning Areas:

Planning of health education strategies, interventions, and programs
Protection of the public in relation to communicable diseases including prevention or control

Learning Objectives:
List two physician factors associated with HPV vaccine recommendation to males ages 11 to 26 years. Discuss physicians' consistent HPV vaccine recommendations to males while national guidelines for permissive vaccination were in effect.

Keyword(s): Adolescent Health, Cancer Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have extensive experience coordinating federally and university funded grants to study physician recommendation of HPV vaccination. Among my scientific interests is the prevention of HPV-related diseases in males and females. I also have formal training in research methods and statistical analyses pertinent to the research in this abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.